Immunological outcomes between Tenofovir versus Zidovudine-based regimens: a retrospective cohort study

• Main Authors: Meshack Lugoba1 (Author), Manase Kilonzi1 (Author), George M Bwire2 (Author), Pacifi que Ndayishimiye1 (Author), Wigilya P Mikomangwa1 (Author), Hamu J Mlyuka1 (Author), Alphonce I Marealle1 (Author), Ritah F Mutagonda1 (Author), Kennedy D Mwambete2 (Author)
• Format: Book
• Published: Archives of Community Medicine and Public Health - Peertechz Publications, 2019-07-11.
• Subjects: Research Article
• Online Access: Connect to this object online.

<p><strong>Background</strong>: Since 2013, Tenofovir (TDF) and Zidovudine (AZT) based regimen are alternatively used as a fi rst line for treatment of HIV in Tanzania. CD4+ cells count, which is recommended after every six months monitors the immunological progression, and used as...